Rukobia (fostemsavir) is a prescription medication used to

New Post Public Reply Private Reply Replies (0) Message Board
My69z
561
Rukobia (fostemsavir) is a prescription medication used to treat HIV-1 infection in adults with multidrug-resistant HIV-1. It's taken orally in combination with other HIV medicines when standard combinations aren't effective:

How it works
Rukobia attaches to a protein on the HIV-1 virus, preventing it from interacting with T cells and reproducing. This slows the spread of infection.

When it's used
Rukobia is used when other antiretrovirals (ARVs) aren't effective due to resistance, intolerance, or safety concerns.

How it's taken
Rukobia is taken orally as a prolonged-release tablet, with a dose of 600 mg twice daily.

Side effects
Serious side effects include unexplained weight loss, severe tiredness, muscle aches, severe headaches, joint pain, numbness or tingling, vision changes, and signs of infection. Other side effects include heart rhythm problems and changes in liver function.

Immune Reconstitution Syndrome, which can include autoimmune disorders
____
https://medicine.yale.edu/news/yale-medicine-...ainst-hiv/
____

Although being a pill combo after all failed antiretrovirals, hats off to Dr. Lataillade for having designed a 1st @ BSM & leading a multi-country trial, to FDA approval.

Rukobia just does not perform even close to LL's level.
Of course the safety comparisons are also just a world of differences.

Two days ago Cytodyn said looking to possibly end needing antiretroviral. My guess is today is for pulling LL HIV into either ViiV or one of the other 2 BP's.

Rights to all Cytodyn's, LL-HIV based projects.

Including a re-filing of BLA.
This time also done right @ multiple countries.

Multiple forms of milestone payments to Cytodyn, later replaced with royalties from all HIV product lines.

Shall see.....

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Explore Legal Action Against iLearningEngines for Fraud

Updated Category News Views 91

Understanding the Investor Landscape The landscape of investor rights is evolving, and in the case of iLearningEngines, Inc., investors find themselves at a significant crossroads. The company, which trades on NASDAQ under the ticker AILE, is currently facing a class action lawsuit led by a dedicated group of investors and the Schall Law Firm. The Class Action Against...

Continue Reading
EditForce Reveals Breakthrough Findings on Myotonic Dystrophy Treatment

Updated Category News Views 327

EditForce's Groundbreaking Research on Myotonic Dystrophy EditForce, Inc. has announced a pivotal breakthrough in the treatment of Myotonic Dystrophy Type 1, significantly enhancing the future of therapeutic options for this challenging condition. The research highlights the efficacy of their innovative PPR platform technology, specifically the CUG-PPR1 protein that...

Continue Reading
dancemoon Reintroduces MoonRoller with Layer Brush Mini

Updated Category News Views 347

The Return of dancemoon MoonRoller and New Layer Brush Mini dancemoon, a pioneer in innovative home cleaning solutions, has officially re-launched its popular flagship product, the dancemoon MoonRoller, alongside the new Layer Brush Mini. This latest offering is now available for purchase globally through the brand's official website and other major e-commerce platforms....

Continue Reading
Carriage Services Prepares for Q3 Earnings Conference Call

Updated Category News Views 94

Carriage Services Announces Earnings Release for Q3 2024 HOUSTON, Carriage Services, Inc. (NYSE: CSV) is set to unveil its third quarter earnings results for 2024. The earnings report is scheduled for release on Wednesday, following the market's closing bell, signaling a vital moment for shareholders and the market at large. Investors are keenly awaiting the insights that...

Continue Reading
Spanish Stock Market Shows Resilience with IBEX 35 Rise

Updated Category News Views 393

Spanish Market Overview The Spanish stock market showed positive momentum recently, with the IBEX 35 index recording a modest gain of 0.19%. This uptick reflects a notable shift in investor sentiment across various sectors, leading to an overall increase in share prices. Leading Sectors Driving Growth The rise in the IBEX 35 was attributed primarily to strong performances...

Continue Reading